- Home
- SNY vs PHLT Comparison
SNY vs PHLT Comparison
Compare SNY & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- PHLT
- Stock Information
- Founded
- SNY 1994
- PHLT 1976
- Country
- SNY France
- PHLT United States
- Employees
- SNY N/A
- PHLT N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- PHLT Other Consumer Services
- Sector
- SNY Health Care
- PHLT Consumer Discretionary
- Exchange
- SNY Nasdaq
- PHLT Nasdaq
- Market Cap
- SNY 116.5B
- PHLT 267.0M
- IPO Year
- SNY N/A
- PHLT N/A
- Fundamental
- Price
- SNY $48.61
- PHLT $4.17
- Analyst Decision
- SNY Buy
- PHLT Buy
- Analyst Count
- SNY 2
- PHLT 1
- Target Price
- SNY $62.50
- PHLT $8.00
- AVG Volume (30 Days)
- SNY 2.2M
- PHLT 249.9K
- Earning Date
- SNY 07-31-2025
- PHLT 08-06-2025
- Dividend Yield
- SNY 3.29%
- PHLT N/A
- EPS Growth
- SNY 39.56
- PHLT N/A
- EPS
- SNY 5.45
- PHLT N/A
- Revenue
- SNY $48,817,552,946.00
- PHLT $128,916,000.00
- Revenue This Year
- SNY $3.39
- PHLT $11.03
- Revenue Next Year
- SNY $7.05
- PHLT $11.23
- P/E Ratio
- SNY $8.92
- PHLT N/A
- Revenue Growth
- SNY N/A
- PHLT 11.76
- 52 Week Low
- SNY $45.80
- PHLT $2.17
- 52 Week High
- SNY $60.12
- PHLT $4.44
- Technical
- Relative Strength Index (RSI)
- SNY 46.26
- PHLT N/A
- Support Level
- SNY $47.99
- PHLT N/A
- Resistance Level
- SNY $49.43
- PHLT N/A
- Average True Range (ATR)
- SNY 0.58
- PHLT 0.00
- MACD
- SNY 0.18
- PHLT 0.00
- Stochastic Oscillator
- SNY 56.15
- PHLT 0.00
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.